Huabao Liu

机构：The Affiliated Yongchuan Hospital of Chongqing Medical University, First People's Hospital of Chongqing, Chongqing Medical University · ORCID：0000-0002-7638-8115

发表论文 34 篇 · 总被引 368 次 · h-index 12

代表论文

• Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B (2022 · Journal of Hepatology · 被引 72)
• Recent developments in the regulation of cholesterol transport by natural molecules (2021 · Phytotherapy Research · 被引 27)
• A novel nomogram to predict evident histological liver injury in patients with HBeAg-positive chronic hepatitis B virus infection (2021 · EBioMedicine · 被引 26)
• Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial (2022 · Journal of Ethnopharmacology · 被引 22)
• Revealing potential anti-fibrotic mechanism of Ganxianfang formula based on RNA sequence (2022 · Chinese Medicine · 被引 21)
• Influence of weight management on the prognosis of steatohepatitis in chronic hepatitis B patients during antiviral treatment (2021 · Hepatobiliary & pancreatic diseases international · 被引 19)